News Focus
News Focus
Followers 29
Posts 6527
Boards Moderated 0
Alias Born 04/20/2010

Re: SkyLimit2022 post# 606845

Wednesday, 07/05/2023 1:44:50 PM

Wednesday, July 05, 2023 1:44:50 PM

Post# of 823386

If you don’t like the ECA or other aspects of the landmark P3, then you have other DCVax-L clinical trials to consider.



I don't need to like the ECA. The FDA needs to, IF the company ever submits anything. But they won't since the data is garbage except in NWBO fantasy land.

One thing we know about the FDA is they want to discuss with the company before an ECA is used, just as Medicenna did. And based on that meeting, the FDA also indicated they want an ECA combined with an internal control arm. This is a hybrid ECA as agreed upon for Medicenna's upcoming rGBM P3. And in those discussions, the FDA made it clear that they need patient level data in the ECA.

You're welcome.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News